Resultados de procura - Martin Augsten
- Mostrando 1 - 19 Resultados de 19
-
1
-
2
-
3
-
4
-
5
-
6
An immunosuppressive macrophage profile attenuates the prognostic impact of CD20-positive B cells in human soft tissue sarcoma por Panagiotis Tsagozis, Martin Augsten, Yifan Zhang, Li Tian, Asle Hesla, Jonas Bergh, Felix Haglund, Nicholas P. Tobin, Monika Ehnman
Publicado 2019Artigo -
7
-
8
Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells por Emarndeena H. Cheteh, Victoria Sarne, Sophia Ceder, Julie Bianchi, Martin Augsten, Helene Rundqvist, Lars Egevad, Arne Östman, Klas G. Wiman
Publicado 2020Artigo -
9
Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death por Emarndeena H. Cheteh, Martin Augsten, Helene Rundqvist, Julie Bianchi, Victoria Sarne, Lars Egevad, Vladimir J.N. Bykov, Arne Östman, Klas G. Wiman
Publicado 2017Artigo -
10
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth por Martin Augsten, Christina Hägglöf, Eleonor Olsson, Claudia Stolz, Panagiotis Tsagozis, Tetyana Levchenko, Mitchell J. Frederick, Åke Borg, Patrick Micke, Lars Egevad, Arne Östman
Publicado 2009Artigo -
11
Prognostic Significance in Breast Cancer of a Gene Signature Capturing Stromal PDGF Signaling por Oliver Frings, Martin Augsten, Nicholas P. Tobin, Joseph W. Carlson, Janna Paulsson, Cristina Peña, Eleonor Olsson, Srinivas Veerla, Jonas Bergh, Arne Östman, Erik L. L. Sonnhammer
Publicado 2013Artigo -
12
Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15 por Francesca Bruzzese, Christina Hägglöf, Alessandra Leone, Elin Sjöberg, Maria Serena Roca, Sara Kiflemariam, Tobias Sjöblom, Peter Hammarsten, Lars Egevad, Anders Bergh, Arne Östman, Alfredo Budillon, Martin Augsten
Publicado 2014Artigo -
13
Forkhead Box F1 Regulates Tumor-Promoting Properties of Cancer-Associated Fibroblasts in Lung Cancer por Roy-Akira Saito, Patrick Micke, Janna Paulsson, Martin Augsten, Cristina Peña, Per Jönsson, Johan Botling, Karolina Edlund, Leif Johansson, Peter Carlsson, Karin Jirström, Kohei Miyazono, Arne Östman
Publicado 2010Artigo -
14
Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells por Pedram Kharaziha, Patricia Q. Rodriguez, Qiao Li, Helene Rundqvist, A-C Björklund, Martin Augsten, Anders Ullén, Lars Egevad, Peter Wiklund, Sten Nilsson, Guido Kroemer, Dan Grandér, Theocharis Panaretakis
Publicado 2012Artigo -
15
Selective activation of oxidized PTP1B by the thioredoxin system modulates PDGF-β receptor tyrosine kinase signaling por Markus Dagnell, Jeroen Frijhoff, Irina Pader, Martin Augsten, Benoît Boivin, Jianqiang Xu, Pankaj Kumar Mandal, Nicholas K. Tonks, Carina Hellberg, Marcus Conrad, Elias S.J. Arnér, Arne Östman
Publicado 2013Artigo -
16
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer por Elin Sjöberg, Max Meyrath, Laura Milde, Mercedes Herrera, John Lövrot, Daniel Hägerstrand, Oliver Frings, Margarita Bartish, Charlotte Rolny, Erik L. L. Sonnhammer, Andy Chevigné, Martin Augsten, Arne Östman
Publicado 2019Artigo -
17
STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer por Cristina Peña, María Virtudes Céspedes, Maja Bradic Lindh, Sara Kiflemariam, Artur Mezheyeuski, Per‐Henrik Edqvist, Christina Hägglöf, Helgi Birgisson, Linda Bojmar, Karin Jirström, Per Sandström, Eleonor Olsson, Srinivas Veerla, Alberto Gallardo, Tobias Sjöblom, Andy Chang, Roger R. Reddel, Ramón Mangues, Martin Augsten, Arne Östman
Publicado 2012Artigo -
18
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy por William C. Stafford, Xiaoxiao Peng, Maria Hägg Olofsson, Xiaonan Zhang, Diane K. Luci, Frank Leigh Lu, Qing Cheng, L. Tresaugues, Thomas S. Dexheimer, Nathan P. Coussens, Martin Augsten, Hanna-Stina Martinsson Ahlzén, Owe Orwar, Arne Östman, Sharon Stone‐Elander, David J. Maloney, Ajit Jadhav, Anton Simeonov, Stig Linder, Elias S.J. Arnér
Publicado 2018Artigo -
19
Zongertinib (BI 1810631), an irreversible HER2 TKI, spares EGFR signaling and improves therapeutic response in preclinical models and patients with HER2-driven cancers por Birgit Wilding, Lydia Woelflingseder, Anke Baum, Krzysztof Chylinski, Gintautas Vainorius, Neil Gibson, Irene C. Waizenegger, Daniel Gerlach, Martin Augsten, Fiona Spreitzer, Yukina Shirai, Masachika Ikegami, Sylvia Tilandyová, Dirk Scharn, Mark Pearson, Johannes Popow, Anna C. Obenauf, Noboru Yamamoto, Shunsuke Kondo, Frans L. Opdam, Annemarie Bruining, Shinji Kohsaka, Norbert Kraut, John V. Heymach, Flavio Solca, Ralph A. Neumüller
Publicado 2024Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer research
Cancer
Medicine
Biochemistry
Internal medicine
Cell biology
Receptor
Genetics
Cancer cell
Chemistry
Immunology
Prostate cancer
Signal transduction
Stromal cell
Tumor microenvironment
Breast cancer
CXCL14
Cancer-Associated Fibroblasts
Chemokine
Chemokine receptor
Metastasis
Pathology
Cell culture
Cell growth
Enzyme
Gene
Growth factor
Immune system
Immunohistochemistry